Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gladman

Showing results (171-180 of 969) with videos related to

Pageof 97
Sort By:
Lupus|July 18, 2012
SLEDAI-2K Responder Index 50 captures 50% improvement in disease activity over 10 yearsZ Touma, D D Gladman, D Ibañez, et al.
Lupus|June 5, 2002
The nature and outcome of infection in systemic lupus erythematosusD D Gladman, F Hussain, D Ibañez, et al.
The Journal of Rheumatology|September 11, 2003
Clinically active serologically quiescent systemic lupus erythematosusDafna D Gladman, Naushad Hirani, Dominique Ibañez, et al.
Annals of the Rheumatic Diseases|September 15, 2011
Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease?Dafna D Gladman, Arane Thavaneswaran, Vinod Chandran, et al.
The Journal of Rheumatology|July 5, 2011
Is there an advantage over SF-36 with a quality of life measure that is specific to systemic lupus erythematosus?Zahi Touma, Dafna D Gladman, Dominique Ibañez, et al.
Arthritis Care & Research|October 29, 2011
Autoantibody response to adjuvant and nonadjuvant H1N1 vaccination in systemic lupus erythematosusMurray B Urowitz, Anoja Anton, Dominique Ibanez, et al.
Lupus|January 15, 2011
SLEDAI-2K 10 days versus SLEDAI-2K 30 days in a longitudinal evaluationZ Touma, M B Urowitz, D Ibañez, et al.
The Journal of Rheumatology|July 17, 2016
Attainment of Minimal Disease Activity Using Methotrexate in Psoriatic ArthritisBarry J Sheane, Arane Thavaneswaran, Dafna D Gladman, et al.
Clinical and Experimental Rheumatology|March 23, 2000
Comparison of clinical and immunogenetic features in familial versus sporadic psoriatic arthritisP Rahman, C T Schentag, M Beaton, et al.
The Journal of Rheumatology|December 1, 1994
Serologically active clinically quiescent systemic lupus erythematosus--predictors of clinical flaresB A Walz LeBlanc, D D Gladman, M B Urowitz
Pageof 97

Showing results (171-180 of 969) with videos related to

Sort By:
Pageof 97
Lupus|July 18, 2012
SLEDAI-2K Responder Index 50 captures 50% improvement in disease activity over 10 yearsZ Touma, D D Gladman, D Ibañez, et al.
Lupus|June 5, 2002
The nature and outcome of infection in systemic lupus erythematosusD D Gladman, F Hussain, D Ibañez, et al.
The Journal of Rheumatology|September 11, 2003
Clinically active serologically quiescent systemic lupus erythematosusDafna D Gladman, Naushad Hirani, Dominique Ibañez, et al.
Annals of the Rheumatic Diseases|September 15, 2011
Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease?Dafna D Gladman, Arane Thavaneswaran, Vinod Chandran, et al.
The Journal of Rheumatology|July 5, 2011
Is there an advantage over SF-36 with a quality of life measure that is specific to systemic lupus erythematosus?Zahi Touma, Dafna D Gladman, Dominique Ibañez, et al.
Arthritis Care & Research|October 29, 2011
Autoantibody response to adjuvant and nonadjuvant H1N1 vaccination in systemic lupus erythematosusMurray B Urowitz, Anoja Anton, Dominique Ibanez, et al.
Lupus|January 15, 2011
SLEDAI-2K 10 days versus SLEDAI-2K 30 days in a longitudinal evaluationZ Touma, M B Urowitz, D Ibañez, et al.
The Journal of Rheumatology|July 17, 2016
Attainment of Minimal Disease Activity Using Methotrexate in Psoriatic ArthritisBarry J Sheane, Arane Thavaneswaran, Dafna D Gladman, et al.
Clinical and Experimental Rheumatology|March 23, 2000
Comparison of clinical and immunogenetic features in familial versus sporadic psoriatic arthritisP Rahman, C T Schentag, M Beaton, et al.
The Journal of Rheumatology|December 1, 1994
Serologically active clinically quiescent systemic lupus erythematosus--predictors of clinical flaresB A Walz LeBlanc, D D Gladman, M B Urowitz
Pageof 97